跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
TGA
/
OLMERTAN COMBI 40/25 olmesartan medoxomil and hydrochlorothiazide 40/25 mg tablet blister pack
Approved
STANDARD
OLMERTAN COMBI 40/25 olmesartan medoxomil and hydrochlorothiazide 40/25 mg tablet blister pack
Pharmacor Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
0cfb35a1f02e3c19
Company
Pharmacor Pty Ltd
Type
Standard
Approval Details
Approval Id
0cfb35a1f02e3c19
Product Name
OLMERTAN COMBI 40/25 olmesartan medoxomil and hydrochlorothiazide 40/25 mg tablet blister pack
Artg Id
286100
Artg Name
OLMERTAN COMBI 40/25 olmesartan medoxomil and hydrochlorothiazide 40/25 mg tablet blister pack
Sponsor
Pharmacor Pty Ltd
Company Detail Path
/organization/pharmacor-sa-pty-ltd
Artg Date
2018-01-29
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/53047fe4309019bfe5477a6877adb68b.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/e56cfb2c40c0a707fc4299d50b7f0ef3.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
0cfb35a1f02e3c19
Type
Standard
Back to TGA Approvals
OLMERTAN COMBI 40/25 olmesartan medoxomil and hydrochlorothiazide 40/25 mg tablet blister pack - TGA Drug Approval Details